Integral Ad Science 株価情報 (NASDAQ: IAS)

Integral Ad Science (NASDAQ:IAS) 株価情報

Integral Ad Science

Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.

Integral Ad Science Holding Corp. - Common Stock

Integral Ad Science Holding Corp

WIIM

Integral Ad Science shares are trading higher after the company reported better-than-expected Q4 sales results and issued Q1 sales guidance above estimates.

News

Guidance

Integral Ad Science Expects Total Revenue Of $128M - $131M For Q1 (Est $126.847M), $588M - $600M For 2025 (Est $588.409M)

Integral Ad Science Expects To Deliver Profitable, Double-digit Revenue Growth In 2025

Integral Ad Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) reported quarterly earnings of $0.09 per share which missed the analyst consensus estimate of $0.10 by 10 percent. This is a 50 percent increase over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $153.04 million which beat the analyst consensus estimate of $148.82 million by 2.83 percent. This is a 13.96 percent increase over sales of $134.29 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Integral Ad Science Q4 2024 GAAP EPS $0.09 Misses $0.10 Estimate, Sales $153.04M Beat $148.82M Estimate

U.S. stock futures rose on Friday following Thursday&#8217;s sell-off. Futures of all benchmark indices advanced in premarket trading, except the small-cap gauge Russell 2000.
Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) fell over 8% on Thursday, dragging the tech-heavy Nasdaq 100 down despite the strong quarter as its gross margins fell sequentially, caused by the ramp-up in the production of its Blackwell chips.
Meanwhile, President Donald Trump escalated tariff threats against Mexico and Canada, saying that it will go into effect as scheduled on March 4, in a social media post. He further threatened additional tariffs on China, following his pledge to impose 25% tariffs on the EU.
Investors await Friday&#8217;s personal consumption expenditure inflation data amid uncertainty over interest rate cuts as it is the Federal Reserve&#8217;s preferred inflation gauge.
The 10-year Treasury yield stood at 4.25%, while the two-year yield was at 4.05%. According <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">to</a> the CME Group's FedWatch tool, there is a 94.5% chance that the Federal Reserve will keep interest rates unchanged for the March meeting.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.27%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.30%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.27%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.06%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose in premarket on Friday. SPY was up 0.35% to $587.09, and QQQ advanced 0.28% to $501.67, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From The Last Session
Most sectors in the S&amp;P 500 ended lower Thursday, with technology and communication services leading the decline. However, financial and energy stocks bucked the trend.
The Nasdaq Composite dropped over 500 points, dragged down by Nvidia&#8217;s 8% plunge after its Q4 earnings.
Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) declined after missing revenue estimates, whereas, SoundHound AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) rose in after-hours after beating analyst expectations. Rocket Lab USA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) shares dropped after a weak first-quarter guidance.
Economic data showed a slight upward revision to fourth quarter GDP according to its second reading released on Thursday. Also, initial jobless claims rose by 22,000 from the previous week to 242,000, the most in over two months and above market expectations of 221,000.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-2.78%</td>
<td>18,544.42</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-1.59%</td>
<td>5,861.57</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.45%</td>
<td>43,239.50 </td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-1.59%</td>
<td>2,139.66</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
Ryan Detrick, the chief market strategist at Carson Research highlighted that the first quarter of a post-election year tends to be &#8220;quite weak&#8221;. &#8220;This choppy start to 2025 isn&#8217;t abnormal. Don&#8217;t panic,&#8221; he added.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">As we&#39;ve noted many times, the first quarter of a post-election year tends to be quite weak. This choppy start to 2025 isn&#39;t abnormal. Don&#39;t panic. <a href="https://t.co/5tQjYeqd6G">pic.twitter.com/5tQjYeqd6G</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1895314476557312425?ref_src=twsrc%5Etfw">February 28, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He also continued reiterating his February seasonality stance via his X posts. He highlighted that junk corporate bonds, also called high-yield bonds, were up the past five days as the S&amp;P 500 was down over 4%.
&#8220;If the end was near like they keep telling us this wouldn&#8217;t be the case. Remain calm, this is simply seasonal late February shenanigans,&#8221; he said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The S&amp;P 500 is down 4% the past five days. High yield bonds are UP the past five days. If the end was near like they keep telling us this wouldn&#39;t be the case. Remain calm, this is simply seasonal late February shenanigans. <a href="https://t.co/FF2TtFJGz5">pic.twitter.com/FF2TtFJGz5</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1895318792634606066?ref_src=twsrc%5Etfw">February 28, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Furthermore, he dismissed the validity of price-to-earnings ratio, saying that there was no &#8220;correlation between P/E multiples and what stocks will do a year later.&#8221;
George Smith, portfolio strategist at LPL Financial highlighted his take on investor sentiment by analyzing survey data from the American Association of Individual Investors and Bank of America Global Fund Manager Survey.
AAII&#8217;s latest sentiment survey reveals significantly bearish sentiment among individual investors for the fourth consecutive week, with the bull-bear spread at a 10-year high. This extreme bearishness, viewed through a contrarian lens, could be a positive signal for stocks, said Smith.
However, the BofA Global Fund Manager Survey presents a more mixed picture, with professional investors cautiously optimistic about the economy but concerned about overvalued U.S. equities. Overall, these surveys suggest a relatively neutral market outlook, aligning with LPL Research&#8217;s neutral stance on equities due to a balance of positive and negative factors, explained Smith.
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep on Friday:
<ul>
<li>January's personal income, spending, core and headline PCE index, advanced U.S. trade balance in goods, retail and wholesale inventories will be out by 8:30 a.m., ET.</li>
</ul>
<ul>
<li>Richmond Fed President Tom Barkin will speak at 8:30 a.m., ET as well.</li>
</ul>
<ul>
<li>February's Chicago business barometer data will be released at 9:45 a.m., ET.</li>
</ul>
<ul>
<li>Chicago Fed President Austan Goolsbee will speak at 10:15 p.m., ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Owens &amp; Minor Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMI#NYSE">OMI</a>) rose 0.78% in the premarket on Friday ahead of its earnings, which will be released before the opening bell. Analysts expect it to report earnings of 52 cents per share on the revenue of $2.69 billion.</li>
</ul>
<ul>
<li>Chart Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTLS#NYSE">GTLS</a>) declined 0.14% as Wall Street expects it to report quarterly earnings of $3.15 per share on revenue of $1.17 billion before the opening bell.</li>
</ul>
<ul>
<li>Integral Ad Science Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) fell 1.55% ahead of its earnings, which will be released before the opening bell. Analysts expect it to report earnings of 25 cents per share on the revenue of $148.83 million.</li>
</ul>
<ul>
<li>HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) was 3.41% lower despite meeting EPS and revenue estimates as it guided for lower than expected second-quarter adjusted EPS between 75 to 85 cents.</li>
</ul>
<ul>
<li>Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) dropped 2.06% as it missed the revenue expectations amid a mixed quarter.</li>
</ul>
<ul>
<li>SoundHound AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) jumped 5.86% after posting a strong quarter and issuing a positive guidance for the next fiscal year.</li>
</ul>
<ul>
<li>Rocket Lab USA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) slumped 10.99% as it reported a weaker than expected first quarter guidance.</li>
</ul>
<ul>
<li>Rapid Micro Biosystems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPID#NASDAQ">RPID</a>) climbed 40.48% as it signed a 5-year global distribution deal with MilliporeSigma.</li>
</ul>
<ul>
<li>Virpax Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) surged 39.04% as it reported positive human study results for its Molecular Envelope Technology, a key component in its Envelta and NobrXiol products, with no moderate to severe adverse events.</li>
</ul>
<ul>
<li>Powell Max Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMAX#NASDAQ">PMAX</a>) zoomed 77.05% as it announced that it will acquire Miracle Media Production from Vision Access Enterprises and M Digital Partners Company. The acquisition is expected to enhance Powell Max&#8217;s services and create synergies.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 1.11% to hover around $69.57 per barrel.
The gold spot index was down by 0.53% to $2,861.73 per ounce. Its last record high was at $2,956.37. The Dollar Index was up 0.12% at the 107.373 level.
Asian markets fell on Friday, including Japan's Nikkei 225, China's CSI 300, Australia's ASX 200, India's S&amp;P BSE Sensex, South Korea's Kospi, and Hong Kong's Hang Seng index. European markets were also mostly lower in trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/44035798/dell-technologies-projects-15-billion-ai-server-revenue-for-fy26-raises-dividend-18-amid-a-mixed-quarter">Dell Technologies Projects $15 Billion AI Server Revenue For FY26, Raises Dividend By 18% Amid A Mixed Quarter</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Government

Market Summary

Futures

Treasuries

Economics

Pre-Market Outlook

Markets

Analyst Ratings

DELL

GTLS

NVDA

PMAX

RKLB

RPID

SOUN

VRPX

US Stocks Likely To Open Higher Following A Sell-Off, 'This Choppy Start To 2025 Isn't Abnormal. Don't Panic,' Says Expert Highlighting Seasonal Weakness In The First Quarter After Elections

<h3>Companies Reporting Before The Bell</h3>
• Frontline (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $282.62 million. 
• Nordic American Tankers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NAT#NYSE">NAT</a>) is estimated to report quarterly earnings at $0.04 per share on revenue of $53.07 million. 
• Fluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNT#NASDAQ">FLNT</a>) is estimated to report quarterly loss at $0.23 per share on revenue of $68.06 million. 
• Recursion Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) is expected to report quarterly loss at $0.41 per share on revenue of $18.17 million. 
• Oxford Square Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXSQ#NASDAQ">OXSQ</a>) is projected to report quarterly earnings at $0.06 per share on revenue of $9.90 million. 
• Integral Ad Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) is estimated to report quarterly earnings at $0.25 per share on revenue of $148.94 million. 
• PAR Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAR#NYSE">PAR</a>) is estimated to report quarterly loss at $0.08 per share on revenue of $99.26 million. 
• ANI Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANIP#NASDAQ">ANIP</a>) is expected to report quarterly earnings at $0.31 per share on revenue of $175.12 million. 
• TeraWulf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $37.36 million. 
• Global Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLP#NYSE">GLP</a>) is estimated to report quarterly earnings at $0.90 per share on revenue of $5.80 billion. 
• Rapid Micro Biosystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPID#NASDAQ">RPID</a>) is expected to report quarterly loss at $0.22 per share on revenue of $7.60 million. 
• FuboTV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) is estimated to report quarterly loss at $0.11 per share on revenue of $444.91 million. 
• Butterfly Network (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>) is expected to report quarterly loss at $0.08 per share on revenue of $21.01 million. 
• Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRP#NYSE">NRP</a>) is projected to report earnings for its fourth quarter. 
• Apellis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) is expected to report quarterly loss at $0.37 per share on revenue of $191.93 million. 
• Calumet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLMT#NASDAQ">CLMT</a>) is estimated to report quarterly loss at $0.36 per share on revenue of $929.11 million. 
• 1stdibs.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DIBS#NASDAQ">DIBS</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $22.02 million. 
• LandBridge (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LB#NYSE">LB</a>) is projected to report quarterly earnings at $0.78 per share on revenue of $244.81 million. 
• Fulgent Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGT#NASDAQ">FLGT</a>) is estimated to report quarterly loss at $0.37 per share on revenue of $75.39 million. 
• Owens &amp; Minor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMI#NYSE">OMI</a>) is estimated to report quarterly earnings at $0.53 per share on revenue of $2.73 billion. 
• Amneal Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRX#NASDAQ">AMRX</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $700.83 million. 
• Banco Latinoamericano (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLX#NYSE">BLX</a>) is likely to report quarterly earnings at $0.44 per share on revenue of $251.03 million. 
• Chart Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTLS#NYSE">GTLS</a>) is expected to report quarterly earnings at $3.23 per share on revenue of $1.18 billion. 
• Alpha Metallurgical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMR#NYSE">AMR</a>) is estimated to report quarterly earnings at $1.12 per share on revenue of $683.10 million. 
• Docebo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCBO#NASDAQ">DCBO</a>) is expected to report quarterly earnings at $0.27 per share on revenue of $56.24 million. 
• Northwest Natural Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NWN#NYSE">NWN</a>) is expected to report quarterly earnings at $1.49 per share on revenue of $395.05 million. 
<h3>Companies Reporting After The Bell</h3>
• BIT Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTCM#NYSE">BTCM</a>) is estimated to report earnings for its fourth quarter. 
• Monroe Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRCC#NASDAQ">MRCC</a>) is expected to report quarterly earnings at $0.27 per share on revenue of $14.99 million. 
• Longeveron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) is projected to report quarterly loss at $0.36 per share on revenue of $660 thousand. 
• Middlesex Water (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSEX#NASDAQ">MSEX</a>) is likely to report quarterly earnings at $0.37 per share on revenue of $45.00 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMRX

ANIP

APLS

BFLY

BTCM

CLMT

DCBO

DIBS

FLGT

FLNT

FUBO

LGVN

MRCC

MSEX

OXSQ

RXRX

WULF

Earnings Scheduled For February 28, 2025

Integral Ad Science Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) will release its financial results for the fourth quarter, before the <a href="https://www.benzinga.com/quote/IAS/earnings">opening bell, on Friday, Feb. 28, 2025.</a>
Analysts expect the New York-based company to report quarterly earnings at 25 cents per share, up from 16 cents per share in the year-ago period. Integral Ad Science projects quarterly revenue of $148.83 million, compared to $134.29 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Jan. 3, Integral Ad Science announced the departure of Tania Secor as Chief Financial Officer and the appointment of Jill Putman as Interim CFO.
Integral Ad Science shares fell 2% to close at $9.65 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/ias/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Scotiabank analyst Nat Schindler initiated coverage on the stock with a Sector Perform rating and a price target of $10 on Dec. 5, 2024. This analyst has an accuracy rate of 65%.</li>
<li>Benchmark analyst Mark Zgutowicz reiterated a Hold rating on Nov. 14, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Oppenheimer analyst Jason Helfstein maintained an Outperform rating and cut the price target from $20 to $18 on Nov. 13, 2024. This analyst has an accuracy rate of 79%.</li>
<li>Truist Securities analyst Youssef Squali maintained a Buy rating and slashed the price target from $18 to $16 on Nov. 13, 2024. This analyst has an accuracy rate of 80%.</li>
<li>Barclays analyst Raimo Lenschow maintained an Equal-Weight rating and raised the price target from $12 to $13 on Aug. 5, 2024. This analyst has an accuracy rate of 72%.</li>
</ul>
Considering buying IAS stock? Here&#8217;s what analysts think:
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/44018351/top-3-utilities-stocks-you-may-want-to-dump-in-february">Top 3 Utilities Stocks You May Want To Dump In February</a></li>
</ul>

Price Target

Trading Ideas

Top Wall Street Forecasters Revamp Integral Ad Science Price Expectations Ahead Of Q4 Earnings

Management

IAS CFO Tania Secor To Depart, Jill Putman Appointed Interim CFO

In addition, IAS is launching its AI-driven Total Media Quality (TMQ) for Kwai product suite to provide advertisers with industry-leading Viewability and Invalid Traffic (IVT) Measurement.

Integral Ad Science Enters Exclusive First-To-Market Content-Level Brand Safety And Suitability Measurement For Advertisers On Kwai For Business

TANIA SECOR, Chief Financial Officer at Integral Ad Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>), executed a substantial insider sell on December 10, according to an SEC filing.
What Happened: SECOR's recent move involves selling 7,504 shares of Integral Ad Science. This information is documented in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001842718/000184271824000123//Archives/edgar/data/1842718/000184271824000123/0001842718-24-000123-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday. The total value is $80,592.
At Wednesday morning, Integral Ad Science shares are up by 1.37%, trading at $11.1.
<h3>Unveiling the Story Behind Integral Ad Science</h3>
Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.
<h3>Understanding the Numbers: Integral Ad Science's Finances</h3>
Positive Revenue Trend: Examining Integral Ad Science's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 10.97% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Communication Services sector.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: With a high gross margin of 79.5%, the company demonstrates effective cost control and strong profitability relative to its peers.
</li>
<li>
Earnings per Share (EPS): Integral Ad Science's EPS reflects a decline, falling below the industry average with a current EPS of 0.1.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.09.
Understanding Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 54.75, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 3.57 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): At 16.06, Integral Ad Science's EV/EBITDA ratio reflects a below-par valuation compared to industry averages signalling undervaluation
</li>
</ul>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Key in Investment Decisions</h3>
Insider transactions serve as a piece of the puzzle in investment decisions, rather than the entire picture.
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
<h3>A Closer Look at Important Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001842718">Check Out The Full List Of Integral Ad Science's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Integral Ad Science Chief Financial Officer Trades $80K In Company Stock

Integral Ad Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $15.2, a high estimate of $18.00, and a low estimate of $10.00. Observing a downward trend, the current average is 17.84% lower than the prior average price target of $18.50. 
<img src="https://www.benzinga.com/files/images/story/2024/1733428916_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The perception of Integral Ad Science by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nat Schindler</td>
<td>Scotiabank</td>
<td>Announces</td>
<td>Sector Perform</td>
<td>$10.00</td>
<td>-</td>
</tr>
<tr>
<td>Jason Helfstein</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$18.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Youssef Squali</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$16.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Matt Farrell</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$16.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Jason Kreyer</td>
<td>Craig-Hallum</td>
<td>Lowers</td>
<td>Buy</td>
<td>$16.00</td>
<td>$18.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Integral Ad Science. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Integral Ad Science compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Integral Ad Science's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Integral Ad Science's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/IAS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Integral Ad Science analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into Integral Ad Science's Background</h2>
Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.
<h3>Understanding the Numbers: Integral Ad Science's Finances</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Over the 3 months period, Integral Ad Science showcased positive performance, achieving a revenue growth rate of 10.97% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Communication Services sector.
Net Margin: Integral Ad Science's net margin excels beyond industry benchmarks, reaching 12.05%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 1.67%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Integral Ad Science's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.41% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Integral Ad Science's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.09.
<h2>Analyst Ratings: Simplified</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What 5 Analyst Ratings Have To Say About Integral Ad Science

Scotiabank analyst Nat Schindler initiates coverage on Integral Ad Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) with a Sector Perform rating and announces Price Target of $10.

Initiation

Scotiabank Initiates Coverage On Integral Ad Science with Sector Perform Rating, Announces Price Target of $10

Integral Ad Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>), a leading global media measurement and optimization platform, today announced plans to expand into China to enable global advertisers with invalid traffic (IVT), fraud, and brand safety and suitability measurement, aligned to international and local standards. With the incorporation of a subsidiary in China, IAS will also offer local support to Chinese advertisers looking to grow their reach beyond China's borders. This expansion will support IAS's long-term international expansion strategy, solving a key challenge for advertisers looking for comprehensive measurement coverage across all markets.

Global

IAS Announces Plans To Expand Into China To Enable Global Advertisers With Invalid Traffic, Fraud, And Brand Safety And Suitability Measurement, Aligned To International And Local Standards

Benchmark analyst Mark Zgutowicz reiterates Integral Ad Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) with a Hold.

Reiteration

Benchmark Reiterates Hold on Integral Ad Science

In the latest quarter, 4 analysts provided ratings for Integral Ad Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>), showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $16.5, along with a high estimate of $18.00 and a low estimate of $16.00. A 10.81% drop is evident in the current average compared to the previous average price target of $18.50. 
<img src="https://www.benzinga.com/files/images/story/2024/1731520955_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of Integral Ad Science among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jason Helfstein</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$18.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Youssef Squali</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$16.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Matt Farrell</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$16.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Jason Kreyer</td>
<td>Craig-Hallum</td>
<td>Lowers</td>
<td>Buy</td>
<td>$16.00</td>
<td>$18.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Integral Ad Science. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Integral Ad Science compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Integral Ad Science's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Integral Ad Science's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/IAS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Integral Ad Science analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Discovering Integral Ad Science: A Closer Look</h2>
Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.
<h3>Integral Ad Science's Financial Performance</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Integral Ad Science's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 13.51%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Communication Services sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Integral Ad Science's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.96% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Integral Ad Science's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 0.82%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Integral Ad Science's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.67%, the company showcases efficient use of assets and strong financial health.
Debt Management: Integral Ad Science's debt-to-equity ratio is below the industry average. With a ratio of 0.13, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Integral Ad Science: 4 Analysts Share Their Views

Truist Securities analyst Youssef Squali maintains Integral Ad Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) with a Buy and lowers the price target from $18 to $16.

Truist Securities Maintains Buy on Integral Ad Science, Lowers Price Target to $16

Piper Sandler analyst Matt Farrell maintains Integral Ad Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) with a Overweight and lowers the price target from $18 to $16.

Piper Sandler Maintains Overweight on Integral Ad Science, Lowers Price Target to $16

Craig-Hallum analyst Jason Kreyer maintains Integral Ad Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) with a Buy and lowers the price target from $18 to $16.

Craig-Hallum Maintains Buy on Integral Ad Science, Lowers Price Target to $16

Integral Ad Science shares are trading lower after Oppenheimer cut its price target on the stock from $20 to $18.

Oppenheimer analyst Jason Helfstein maintains Integral Ad Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) with a Outperform and lowers the price target from $20 to $18.

Oppenheimer Maintains Outperform on Integral Ad Science, Lowers Price Target to $18

Legal

Press Releases

IAS Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Integral Ad Science Holding Corp. (IAS) Shareholders of Deadline in Securities Fraud Class Action Lawsuit

Deadline Alert: Integral Ad Science Holding Corp. (IAS) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Shareholders of Integral Ad Science Holding Corp. Should Contact The Gross Law Firm Before March 31, 2025 to Discuss Your Rights – IAS

Integral Ad Science Holding Corp. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - IAS

Small Cap

Integral Ad Science Holding Corp. (IAS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

INTEGRAL AD SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Integral Ad Science Holding Corp. - IAS

Contact Levi & Korsinsky by March 31, 2025 Deadline to Join Class Action Against Integral Ad Science Holding Corp.(IAS)

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 31, 2025 in Integral Ad Science Lawsuit - IAS

IAS Reports Fourth Quarter and Full Year 2024 Financial Results

Integral Ad Science Holding Corp. (IAS) Investors: March 31, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

Comments

Integral Ad Science

ニュース

パートナーシップ

ベンジンガ・グローバル